P2Y12 Inhibitor Monotherapy After a Short Dual Antiplatelet Therapy Versus Standard-Term Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Meta-Analysis.
Ai-Chen HoUgochukwu EgolumShanea ParkerJordan DimmelAndrew HawkinsHua LingPublished in: Clinical drug investigation (2020)
This meta-analysis showed a significantly lowered risk of major bleeding and similar benefits of P2Y12 inhibitor monotherapy after short-term DAPT compared with standard-term DAPT in patients undergoing PCI.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- patients undergoing
- acute coronary syndrome
- systematic review
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- meta analyses
- coronary artery bypass grafting
- atrial fibrillation
- preterm infants
- combination therapy
- open label
- case control
- gestational age
- left ventricular
- randomized controlled trial
- heart failure
- study protocol